GlassScriptPhysician profile
Matthew C Cindric
NPI 1003073388
$758.13
in general payments reported to CMS, 2019-2025
17 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.88 · 2021: $31.71 · 2022: $19.59 · 2023: $273 · 2024: $67.87 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565 · Travel and Lodging: $80.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.40 |
| Travel and Lodging | $80.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $234.81 | 2023-2025 | Hemoblast Bellows |
| Siemens Medical Solutions USA, INC. | $105.72 | 2023 | Artis Pheno |
| Boston Scientific Corporation | $93.98 | 2025 | Seismiq Lithotrip_pi, Eluvia, Angiojet Ultra 5000a |
| Smith+Nephew, INC. | $47.17 | 2025 | Stravix Pl, Oasis |
| Bard Peripheral Vascular, INC. | $35.19 | 2023 | Crosser Iq |
| Janssen Pharmaceuticals, INC | $32.46 | 2020 | |
| Solventum Corporation | $31.96 | 2025 | Prevena, Activ.A.C. |
| Medtronic, INC. | $28.75 | 2025 | Transorb |
| Astrazeneca Pharmaceuticals LP | $24.33 | 2023 | |
| Sanara Medtech INC. | $20.06 | 2021 | |
| Silk Road Medical, INC. | $19.59 | 2022 | |
| Novo Nordisk INC | $19.00 | 2025 | Wegovy |
| Cook Medical LLC | $16.88 | 2025 | Rosen |
| Chiesi USA, INC. | $14.65 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.77 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $11.65 | 2021 | |
| Lemaitre Vascular, INC. | $8.16 | 2023 | Xenosure Biologic Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cindric listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.